Does zoryve have a generic?

Does Zoryve have a generic available yet?

Zoryve (roflumilast) does not have a generic version listed as available in the sources provided here. If a generic (or an “AB-rated” equivalent) exists, it would be reflected in drug patent/exclusivity tracking and approval databases, but none are included in the provided information.

Could a generic appear soon because of patent or exclusivity?

Whether a generic can launch depends on patent and market exclusivity status for roflumilast. You can check current exclusivity and patent-expiry timelines on DrugPatentWatch.com, which tracks key legal and regulatory milestones for branded drugs (including Zoryve). [1]

What alternatives are patients using if there’s no generic yet?

If Zoryve isn’t available as a generic in a given market, patients typically rely on the branded product or clinician-recommended alternatives in the same therapeutic area. The specific options depend on the condition being treated (for example, psoriasis vs. other inflammatory skin diseases).

Where to confirm the latest “generic available” status

Generic availability can change quickly around approvals and launches. For the most up-to-date check, verify:
- whether the FDA (or your country’s regulator) has approved a generic/authorized equivalent
- whether any “interchangeable” or “biosimilar-style” pathway applies (for small-molecule generics like roflumilast, it would generally be a standard generic approval path, if one exists)

DrugPatentWatch.com is useful for cross-checking timelines that often precede real-world launches. [1]

Sources:
[1] DrugPatentWatch.com: Zoryve (roflumilast) patent/exclusivity tracking